Iconic Therapeutics Financing
Iconic Therapeutics Inc, Corporation just had published form D for $48.56 million equity financing. The date of first sale was 2015-12-24. Iconic Therapeutics was able to finance itself with $48.56 million. That is 100.00% of the fundraising. The total offering amount was $48.56 million. This form was filed on 2016-10-31. The reason for the financing was: Proceeds will be used for general corporate purposes including, but not limited to, executive salaries..
Iconic Therapeutics is based in California. The filler’s business is Biotechnology. The form was submitted by William L Greene CEO. The company was incorporated more than five years ago. The filler’s address is: 7000 Shoreline Court, Suite 270, South San Francisco, Ca, California, 94080. William Greene is the related person in the form and it has address: 395 Oyster Point Boulevard, Suite 515, South San Francisco, Ca, California, 94080. Link to Iconic Therapeutics Filing: 000163372316000007.
Analysis of Iconic Therapeutics Offering
On average, startups in the Biotechnology sector, sell 73.77% of the total offering amount. Iconic Therapeutics sold 100.00% of the offering. Could this mean that the trust in Iconic Therapeutics is high? The average offering amount for companies in the Biotechnology industry is $3.08 million. The total amount raised is 1,476.66% bigger than the average for companies in the Biotechnology sector. The minimum investment for this offering is set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Iconic Therapeutics Also
The Form D signed by William L Greene might help Iconic Therapeutics Inc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.